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Rhinophyma represents a progressive deformity of the nose which leads to cosmetic disfigurement and has a significant
impact on the patient’s quality of life. )is pathological entity originates from hyperplasia of sebaceous gland tissue,
connective tissue, and vessels of the nose and is associated with rosacea and more specifically, stage III rosacea. Surgical
treatment is the method of choice. We present five cases of rhinophyma that we treated with microdebrider-assisted excision.
)e procedure was divided in two main steps: scalpel excision of the main bulk of the rhinophyma and then further
contouring with the microdebrider. All patients had weekly follow-up for the first four weeks, and then three-monthly. All
patients had uneventful recovery and satisfactory cosmetic outcomes. No postoperative infections or other complications
were reported in our case series. )e use of the microdebrider reduces the operating time, preserves the islands of skin
regeneration, and allows finer manipulations than the standard scalpel techniques. Microdebrider-assisted rhinophyma
excision is a safe approach, with good aesthetic results. Larger series of patients need to be examined in order to establish the
value of the method.
1. Introduction
Rhinophyma is a rare condition, affecting predominantly
Caucasian males, with a male-to-female ratio of 12–30 : 1
[1–4]. Despite the fact that the pathology is known in the
medical world since 1845 (term introduced by Hebra,
deriving from the Greek synthetics “rhis” and “phyma”,
which means growth of the nose [1, 5]), its exact path-
ogenesis still remains unclear De novo rhinophyma is also
well recognized. It tends to occur in age above 50 years and
is a benign dermatological disease, with cosmetic, func-
tional, and psychosocial effects. Various aetiopathogenic
theories have been presented and even more treatment
modalities have been reported, from medical therapy for
early stage disease to different surgical excision
techniques.
We present our experience of five rhinophyma cases
treated in our department using the microdebrider-assisted
technique, comprising a combination of partial thickness
skin excision with a scalpel followed by microderider final
contouring.
2. Materials and Methods
Five patients were diagnosed with rhinophyma between the
years 2010 and 2018. )ey were all White British males
between 64–77 years of age. )e main complaint of all
patients was cosmetic unsightly appearance of the nose;
however, four patients complained also of nasal airway
obstruction. One patient admitted the psychological impact
of the deformity. Two of the patients in the study group
underwent revision surgery, having had primary surgery at a
different institution, one with laser and the other with simple
scalpel excision.)e duration of symptoms varied between 2
and 6 years, with an average of 4 years. None of the patients
had history of rosacea. One patient admitted ex-heavy al-
cohol consumption, one moderate drinking, and three
nondrinkers. )e deformities have mainly affected the
dorsum of the nose; however, it also involved the tip,
dorsum, and left alar subunit in one of the recurrence cases
(Table 1).
All five patients underwent microdebrider-assisted
rhinophyma excision as day-case surgery. After the initial
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consultation and surgical planning, they were seen once
again at the consent clinic prior to the day of surgery and
preoperative clinical photographs (standard nose series)
were obtained. Under general anaesthesia, the initial ex-
cision of the main rhinophyma bulk was performed using a
no. 10 blade, aiming to respect the nasal subunits. )is first
stage was followed by microdebrider contouring, using a
straight microdebrider handpiece (Medtronic Straightshot
M4 Microdebrider). )e surgeon paid attention to avoid
extensive damage to the deep dermis that will eventually
enable skin regeneration. Also, great care was taken not to
destruct the underlying cartilaginous structures. Haemo-
stasis was achieved with bipolar diathermy, direct pressure,
and topical application of adrenaline 1 : 10.000. Excised
tissues were subjected to histopathological analysis. )e
raw area was covered with Jelonet paraffin gauze and
chloramphenicol ointment, and the patients were dis-
charged on a week’s course of broad-spectrum oral anti-
biotics. All patients had weekly follow-up for the first
month and then three-monthly follow-up appointments up
to 12 months, when they were discharged.
3. Results
)e most common histopathological findings included
nodular pieces of skin with dermal fibrosis and dilated,
plugged hair follicles together with sebaceous gland hy-
perplasia. No dysplasias or malignancies were identified in
our case series. All patients were pleased with their out-
comes, they were more socially active, and their confidence
improved. No recurrence was reported in our study group,
and the patients did not require any additional medical
treatment or any further aesthetic surgical procedures.
(Figures 1–3)
4. Discussion
Rhinophyma is closely associated with acne rosacea and
more specifically, type III of acne rosacea [6, 7]. Another
possible aetiologic factor is colonization of the sebaceous
glands with Demodex folliculorum [6, 8]. None of the
above has been proven to be an established causative factor
for the formation of rhinophyma. Moreover, there is a
discrepancy between the age and gender affected by
rosacea and rhinophyma. )e former affects mainly
women of a younger age, while the latter affects elderly
male patients [6].
)e surgeon should keep in mind the incidence of basal
cell carcinoma (BCC), which has been reported to be be-
tween 5% and 10% in the rhinophymatous tissue [1, 9].
Other pathologies in the differential diagnosis are squamous
cell carcinoma (SCC), sebaceous carcinoma, angiosarcoma,
metastatic disease, granuloma eosinophiliacum, sarcoidosis,
and lymphoma [4, 10–16].
Medical treatment has been employed, especially in the
early stages of rhinophyma, aiming to slow down its pro-
gression. Low-dose isotretinoin has been used in the
management of early rhinophyma [17]. Another potentially
useful strategy is the administration of tamoxifen, as it is
proven to reduce the production and secretion of TGFb2 by
rhinophyma-associated fibroblasts [18, 19]. )ere is no solid
evidence in the literature confirming that the above-
mentioned treatments are successful.
)e mainstay in the treatment of rhinophyma is surgery.
Today, there are numerous methods available, but un-
fortunately, the literature is lacking large series and safe
conclusions on the outcomes of each method.)e principles
of surgical treatment are similar, based on the excision of the
nasal skin and secondary healing of the defect.
Since the first treatment of rhinophyma by Dieffenbach
in 1845 (excision and primary closure) and von Langenbeck
in 1851 (excision and secondary healing), several methods
have been introduced, and the basic axons of development
are haemostasis and bloodless surgical field, satisfactory
aesthetic outcome, and reduction of surgical time [4].
Cryosurgery was first introduced in 1970 as a treatment
option for rhinophyma [20]. Main advantages are minimal
bleeding, little pain, and no destruction of the underlying
nasal cartilages if used appropriately. On the other hand, it
can result is dyschromia and scarring [21]. Blade excision
remains one of the widely used methods. A modification is
the Shaw heated scalpel which cuts tissue and coagulates
blood vessels at the same time. Disadvantages of this method
are postoperative pain, mild scarring, and slight nasal alar
collapse [22]. Another heat-delivery instrument that has
been successfully used is Coblation. It raises the temperature
to 60°C–70°C, compared to the Shaw blade, which reaches
temperatures from 150°C to 200°C. In that way, Coblation
ensures bloodless field and minimal pain. Disadvantages of
the method are hypopigmentation and prolonged erythema
[23, 24]. Other surgical methods include the use of the
harmonic ultrasound scalpel [25], dermabrasion [26],
electrosurgery [27, 28], and Versajet hydrosurgery system
[29]. In addition, laser-assisted treatments have been
Table 1: Patient characteristics and symptoms on presentation.




obstruction Main symptom Deformed nasal subunits
1 M 77 3 New Yes Nasal deformity, obstruction, andpsychological effect Tip
2 M 64 2 New No Nasal deformity Tip
3 M 66 5 Recurrence Yes Nasal deformity and obstruction Tip, dorsum, and left alarsubunit
4 M 71 6 Recurrence Yes Nasal deformity and obstruction Tip
5 M 70 4 New Yes Nasal deformity and obstruction Tip
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described, including Co2 laser [30–32], Erbium:YAG laser
[33, 34], and the diode laser [35, 36]. Also, grafting tech-
niques and the subunit method have been used. )e latter
aims to address the hypertrophic sebaceous tissues, the
excess skin problem, and also the destruction of support
[37].
Microdebrider-assisted rhinophyma excision is not a
new method in the literature, although few cases have
(a) (b) (c)
Figure 1: Preoperative presentation. Obvious deformity of the nasal tip and dorsum, also causing nasal obstruction.
(a) (b)
Figure 2: Intraoperative photographs after the final sculpturing using the macrodebrider.
(a) (b) (c)
Figure 3: Postopeartive photographs, showing the final outcome after the initial healing period.
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been presented up to date. Farris et al. presented three
cases treated with blade excision and microdebrider
sculpturing or microdebrider excision alone [38]. We
have followed a two-stage approach in the five cases that
we present. Scalpel blade excision allows quick removal
of the main tissue bulk and obtaining of tissue samples
for histology, while the use of the microdebrider is
beneficial for quick contouring and shaping of the nasal
subunits, reducing the risk of damage to the underlying
cartilaginous structures. We believe that a straight
microdebrider handpiece is appropriate for tip re-
finement and work around the nasal alae. )e preser-
vation of deeper skin layers allows re-epithelialisation
with less scarring and also the tactile feedback that the
surgeon takes from the instrument. As it is a relatively
quick method, it reduces the intraoperative blood loss
and the risk of infections. All our patients recovered well,
with no postoperative complications and were satisfied
with the aesthetic outcome. Our case series needed re-
vision surgery, either for recurrence or aesthetic
improvements.
We should not forget the psychological impact of rhi-
nophyma and the stigmatization it may bring about to the
patients. A study by Bohm et al. revealed higher risk of
depression and anxiety among patients suffering from
rosacea or rhinophyma compared with the general pop-
ulation. Especially patients with rhinophyma had more
chances to be rejected by others and felt disfigured. Obvi-
ously, all the abovementioned lead to the conclusion that
acne rosacea and rhinophyma can affect the patients’ quality
of life [39]. )e clinician should always keep that in mind
and consider psychiatric cotreatment if necessary. All our
patients felt significant psychological improvement after the
recovery period.
Finally, an equally important issue when it comes to
method selection is cost of the equipment used. Nowadays,
costs represent a main concern in many countries, and there
is a variable set of circumstances in which potentially scarce
equipment often force surgeons to choose only the best
option available. We believe that microdebrider-assisted
rhinophyma excision is cost effective, considering that it
requires less theatre time and the equipment used is non-
specific and readily available in most places with a general
rhinology service [40].
5. Conclusion
Rhinophyma has a quite rare pathology with functional,
aesthetic, and psychological impact.)e problem should be
evaluated in its entirety and addressed in the most ap-
propriate way according to the surgeon’s opinion. A
number of techniques are available including the micro-
debrider-assisted excision. )is method is relatively fast,
allows fine sculpturing, and leaves adequate tissue sample
for histology. )e postoperative results are encouraging,
there is a low recurrence rate, and the cosmetic result is
satisfactory. We also believe that this technique can be
easily mastered by surgeons who have experience in the use
of microdebriders.
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